Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Posted: CEI and Tag Report, Pre-NOC changes, Duration Document update and Quarterly Review
-
Happy Monday @Manufacturer and @agency
To start your week off on an exciting note, PAAB has a few announcements to share:
- The Quarterly CEI Report and PAAB Tag Report for Q3 have been posted.
- The PAAB Forum Quarterly Review for Q3 has been posted.
- An updated Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising has been posted. An annotated version will be posted for 6 months as a reference point of the changes.
- In case you missed last weeks announcement, we have posted an updated approach to the pre-NOC review process that will allow for more pieces to be submitted pre-NOC and prior to the final draft stage of the PM. Learn more here.
Please reach out with comments and questions below.
Have a great week
PAAB -
Happy Monday @Manufacturer and @agency
To start your week off on an exciting note, PAAB has a few announcements to share:
- The Quarterly CEI Report and PAAB Tag Report for Q3 have been posted.
- The PAAB Forum Quarterly Review for Q3 has been posted.
- An updated Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising has been posted. An annotated version will be posted for 6 months as a reference point of the changes.
- In case you missed last weeks announcement, we have posted an updated approach to the pre-NOC review process that will allow for more pieces to be submitted pre-NOC and prior to the final draft stage of the PM. Learn more here.
Please reach out with comments and questions below.
Have a great week
PAAB@jennifer-carroll Yay! Thanks for this!
One remaining question from the previous report: can there be some guidance on why tags were deemed invalid? We were almost looking forward to that following the previous exchange (https://forum.paab.ca/topic/3159/paab-efiles-tag-and-cei-report-q2-2023/4?_=1701119019940) -
@jennifer-carroll Yay! Thanks for this!
One remaining question from the previous report: can there be some guidance on why tags were deemed invalid? We were almost looking forward to that following the previous exchange (https://forum.paab.ca/topic/3159/paab-efiles-tag-and-cei-report-q2-2023/4?_=1701119019940)Apologies @costeap, I totally let that slip my mind.
Please see the revised page and PDF with the additional information requested in your previous feedback.
Thank you for reminding me.
-
Apologies @costeap, I totally let that slip my mind.
Please see the revised page and PDF with the additional information requested in your previous feedback.
Thank you for reminding me.
@jennifer-carroll Thank you so much! This should help us learn
